Cyramza (Ramucirumab) Dosing

HomeCyramza (Ramucirumab) Dosing

Medical Evidence cyramza

Generic name : Ramucirumab.

Trade name : Cyramza.

Manufacturer information :

Cyramza is manufactured by Eli Lilly and Company.

Cyramza FDA Approval :

Cyramza First approved April 21st, 2014.

Dosage form :

Injection:

  • 100 mg/10 mL (10 mg per mL) solution, single-dose vial.
  • 500 mg/50 mL (10 mg per mL) solution, single-dose vial.

Cyramza Indications and Usage :

  • Gastric Cancer.
  • Non-Small Cell Lung Cancer.
  • Colorectal Cancer.

Cyramza (Ramucirumab) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.